Dexcom CEO Terry Gregg reviews the tremendous growth the company saw in 2013 and how the company is improving the quality of life for diabetics. TheStreet's Jill Malandrino reports from the Nasdaq MarketSite in New York.
Jim Cramer says he prefers Celgene to Gilead, and Walgreens Boots Alliance to Express Scripts.
Jim Cramer remains a fan of industrials, transports, banks and domestic oil producers.
Here are Monday's top research calls, including upgrades for Chevron, Macy's and Qualcomm, and downgrades for Home Depot, Lowe's, Exxon Mobil, Nike and Nordstrom.